Graded TTCE for Post-Embolization PAVM Monitoring



Status:Recruiting
Conditions:Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 89
Updated:11/16/2018
Start Date:October 2016
End Date:October 2020
Contact:Scott O Trerotola, MD
Email:streroto@uphs.upenn.edu
Phone:(215) 615-3540

Use our guide to learn which trials are right for you!

Correlation of Graded Transthoracic Contrast Echocardiography With Chest CT Findings After Pulmonary Arteriovenous Malformation Embolization in Patients With Hereditary Hemorrhagic Telangiectasia, 2016

Current HHT guidelines recommend CT scan to detect new or recurrent PAVMs after
embolotherapy. Recent studies using transthoracic contrast echocardiography (TTCE) shunt
grade for PAVM screening suggest that graded TTCE can accurately predict the size of PAVMs on
chest CT and their amenability to embolization. This study's purpose is to evaluate whether
TTCE shunt grade can also accurately predict PAVM size and amenability to treatment in
patients who are post-embolization.

Embolization is the standard of care for pulmonary arteriovenous malformations (PAVMs) in the
Hereditary Hemorrhagic Telangiectasia (HHT) population. PAVMs are abnormal connections
between the veins and arteries and result in right-to-left shunting of blood within the
lungs. Successful embolization results in PAVM resolution and decreases the complications
associated with right-to-left shunting. Current guidelines recommend follow-up with interval
chest CT scan to determine treatment success and detect new or recurrent PAVMs after
embolization. This results in significant radiation exposure to the relatively young HHT
population. An alternative to chest CT is graded transthoracic contrast echocardiography
(TTCE), which measures the amount of right-to-left shunting within the lung and assigns a
grade based on this amount. TTCE has the advantage of being radiation free compared to chest
CT. To date, graded TTCE has only been studied as a screening tool for PAVMs. These studies
have shown that graded TTCE is highly sensitive in detecting PAVMs and is comparable to chest
CT when screening for PAVMs. Results indicate that TTCE grade can accurately predict PAVM
size on chest CT and predict whether PAVMs are amenable to embolization. However, no studies
have compared graded TTCE and chest CT in patients who are post-embolization and it is
therefore unknown whether graded TTCE can be used in patients who have undergone PAVM
embolization. The current study seeks to correlate post-embolization TTCE grade with chest CT
findings to determine whether TTCE can accurately predict PAVM size and amenability to
treatment in the post-embolization population.

Inclusion Criteria:

- Age range 18-89 years old

- Diagnosis of Hereditary Hemorrhagic Telangiectasia by the Curacao criteria

- Prior diagnosis of one or more PAVMs treated by embolotherapy

- Chest CT performed within the Penn system for surveillance of PAVMs after \
embolotherapy

Exclusion Criteria:

- Known PAVM recurrence on most recent chest CT with feeding artery size amenable to
repeat embolotherapy

- Known history of intracardiac shunt

- Discovery of intracardiac shunt during transthoracic contrast echocardiography
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Phone: 215-615-3540
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials